Skip to main content
Top
Published in: Journal of Inflammation 1/2010

Open Access 01-12-2010 | Research

Characterization of protein tyrosine phosphatase H1 knockout mice in animal models of local and systemic inflammation

Authors: Claudia Patrignani, David T Lafont, Valeria Muzio, Béatrice Gréco, Rob Hooft van Huijsduijnen, Paola F Zaratin

Published in: Journal of Inflammation | Issue 1/2010

Login to get access

Abstract

Background

PTPH1 is a protein tyrosine phosphatase expressed in T cells but its effect on immune response is still controversial. PTPH1 dephosphorylates TCRzeta in vitro, inhibiting the downstream inflammatory signaling pathway, however no immunological phenotype has been detected in primary T cells derived from PTPH1-KO mice. The aim of the present study is to characterize PTPH1 phenotype in two in vivo inflammatory models and to give insights in possible PTPH1 functions in cytokine release.

Methods

We challenged PTPH1-KO mice with two potent immunomodulatory molecules, carrageenan and LPS, in order to determine PTPH1 possible role in inflammatory response in vivo. Cytokine release, inflammatory pain and gene expression were investigated in challenged PTPH1-WT and KO mice.

Results

The present study shows that carrageenan induces a trend of slightly increased spontaneous pain sensitivity in PTPH1-KO mice compared to WT (wild-type) littermates, but no differences in cytokine release, induced pain perception and cellular infiltration have been detected between the two genotypes in this mouse model. On the other hand, LPS-induced TNFα, MCP-1 and IL10 release was significantly reduced in PTPH1-KO plasma compared to WTs 30 and 60 minutes post challenge. No cytokine release modulation was detectable 180 minutes post LPS challenge.

Conclusion

In conclusion, the present study points out a slight potential role for PTPH1 in spontaneous pain sensitivity and it indicates that this phosphatase might play a role in the positive regulation of the LPS-induced cytokines release in vivo, in contrast to previous reports indicating PTPH1 as potential negative regulator of immune response.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ulevitch RJ, Mathison JC, da Silva CJ: Innate immune responses during infection. Vaccine. 2004, 22 (Suppl 1): S25-S30. 10.1016/j.vaccine.2004.08.013.PubMedCrossRef Ulevitch RJ, Mathison JC, da Silva CJ: Innate immune responses during infection. Vaccine. 2004, 22 (Suppl 1): S25-S30. 10.1016/j.vaccine.2004.08.013.PubMedCrossRef
2.
go back to reference Ulevitch RJ: Therapeutics targeting the innate immune system. Nat Rev Immunol. 2004, 4: 512-520. 10.1038/nri1396.PubMedCrossRef Ulevitch RJ: Therapeutics targeting the innate immune system. Nat Rev Immunol. 2004, 4: 512-520. 10.1038/nri1396.PubMedCrossRef
3.
go back to reference Mustelin T, Tasken K: Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem J. 2003, 371: 15-27. 10.1042/BJ20021637.PubMedPubMedCentralCrossRef Mustelin T, Tasken K: Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem J. 2003, 371: 15-27. 10.1042/BJ20021637.PubMedPubMedCentralCrossRef
4.
go back to reference Qu CK, Nguyen S, Chen J, Feng GS: Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development. Blood. 2001, 97: 911-914. 10.1182/blood.V97.4.911.PubMedCrossRef Qu CK, Nguyen S, Chen J, Feng GS: Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development. Blood. 2001, 97: 911-914. 10.1182/blood.V97.4.911.PubMedCrossRef
5.
go back to reference Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A: Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003, 34: 148-150. 10.1038/ng1156.PubMedCrossRef Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A: Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003, 34: 148-150. 10.1038/ng1156.PubMedCrossRef
6.
go back to reference Feng GS: Shp-2 tyrosine phosphatase: signaling one cell or many. Exp Cell Res. 1999, 253: 47-54. 10.1006/excr.1999.4668.PubMedCrossRef Feng GS: Shp-2 tyrosine phosphatase: signaling one cell or many. Exp Cell Res. 1999, 253: 47-54. 10.1006/excr.1999.4668.PubMedCrossRef
7.
go back to reference An H, Zhao W, Hou J, Zhang Y, Xie Y, Zheng Y: SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity. 2006, 25: 919-928. 10.1016/j.immuni.2006.10.014.PubMedCrossRef An H, Zhao W, Hou J, Zhang Y, Xie Y, Zheng Y: SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity. 2006, 25: 919-928. 10.1016/j.immuni.2006.10.014.PubMedCrossRef
8.
go back to reference Tsui FW, Martin A, Wang J, Tsui HW: Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1. Immunol Res. 2006, 35: 127-136. 10.1385/IR:35:1:127.PubMedCrossRef Tsui FW, Martin A, Wang J, Tsui HW: Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1. Immunol Res. 2006, 35: 127-136. 10.1385/IR:35:1:127.PubMedCrossRef
9.
go back to reference Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC: PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science. 2004, 303: 685-689. 10.1126/science.1092138.PubMedCrossRef Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC: PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science. 2004, 303: 685-689. 10.1126/science.1092138.PubMedCrossRef
10.
go back to reference Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y: Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev. 2008, 29: 697-725. 10.1210/er.2008-0015.PubMedPubMedCentralCrossRef Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y: Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev. 2008, 29: 697-725. 10.1210/er.2008-0015.PubMedPubMedCentralCrossRef
11.
go back to reference Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC: A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004, 75: 330-337. 10.1086/422827.PubMedPubMedCentralCrossRef Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC: A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004, 75: 330-337. 10.1086/422827.PubMedPubMedCentralCrossRef
12.
go back to reference Young JA, Becker AM, Medeiros JJ, Shapiro VS, Wang A, Farrar JD: The protein tyrosine phosphatase PTPN4/PTP-MEG1, an enzyme capable of dephosphorylating the TCR ITAMs and regulating NF-kappaB, is dispensable for T cell development and/or T cell effector functions. Mol Immunol. 2008, 45: 3756-3766. 10.1016/j.molimm.2008.05.023.PubMedPubMedCentralCrossRef Young JA, Becker AM, Medeiros JJ, Shapiro VS, Wang A, Farrar JD: The protein tyrosine phosphatase PTPN4/PTP-MEG1, an enzyme capable of dephosphorylating the TCR ITAMs and regulating NF-kappaB, is dispensable for T cell development and/or T cell effector functions. Mol Immunol. 2008, 45: 3756-3766. 10.1016/j.molimm.2008.05.023.PubMedPubMedCentralCrossRef
13.
go back to reference Han S, Williams S, Mustelin T: Cytoskeletal protein tyrosine phosphatase PTPH1 reduces T cell antigen receptor signaling. Eur J Immunol. 2000, 30: 1318-1325. 10.1002/(SICI)1521-4141(200005)30:5<1318::AID-IMMU1318>3.0.CO;2-G.PubMedCrossRef Han S, Williams S, Mustelin T: Cytoskeletal protein tyrosine phosphatase PTPH1 reduces T cell antigen receptor signaling. Eur J Immunol. 2000, 30: 1318-1325. 10.1002/(SICI)1521-4141(200005)30:5<1318::AID-IMMU1318>3.0.CO;2-G.PubMedCrossRef
14.
go back to reference Gjorloff-Wingren A, Saxena M, Han S, Wang X, Alonso A, Renedo M: Subcellular localization of intracellular protein tyrosine phosphatases in T cells. Eur J Immunol. 2000, 30: 2412-2421. 10.1002/1521-4141(2000)30:8<2412::AID-IMMU2412>3.0.CO;2-J.PubMedCrossRef Gjorloff-Wingren A, Saxena M, Han S, Wang X, Alonso A, Renedo M: Subcellular localization of intracellular protein tyrosine phosphatases in T cells. Eur J Immunol. 2000, 30: 2412-2421. 10.1002/1521-4141(2000)30:8<2412::AID-IMMU2412>3.0.CO;2-J.PubMedCrossRef
15.
go back to reference Sozio MS, Mathis MA, Young JA, Walchli S, Pitcher LA, Wrage PC: PTPH1 is a predominant protein-tyrosine phosphatase capable of interacting with and dephosphorylating the T cell receptor zeta subunit. J Biol Chem. 2004, 279: 7760-7769. 10.1074/jbc.M309994200.PubMedCrossRef Sozio MS, Mathis MA, Young JA, Walchli S, Pitcher LA, Wrage PC: PTPH1 is a predominant protein-tyrosine phosphatase capable of interacting with and dephosphorylating the T cell receptor zeta subunit. J Biol Chem. 2004, 279: 7760-7769. 10.1074/jbc.M309994200.PubMedCrossRef
16.
go back to reference Bauler TJ, Hughes ED, Arimura Y, Mustelin T, Saunders TL, King PD: Normal TCR signal transduction in mice that lack catalytically active PTPN3 protein tyrosine phosphatase. J Immunol. 2007, 178: 3680-3687.PubMedCrossRef Bauler TJ, Hughes ED, Arimura Y, Mustelin T, Saunders TL, King PD: Normal TCR signal transduction in mice that lack catalytically active PTPN3 protein tyrosine phosphatase. J Immunol. 2007, 178: 3680-3687.PubMedCrossRef
17.
go back to reference Bauler TJ, Hendriks WJ, King PD: The FERM and PDZ domain-containing protein tyrosine phosphatases, PTPN4 and PTPN3, are both dispensable for T cell receptor signal transduction. PLoS ONE. 2008, 3: e4014-10.1371/journal.pone.0004014.PubMedPubMedCentralCrossRef Bauler TJ, Hendriks WJ, King PD: The FERM and PDZ domain-containing protein tyrosine phosphatases, PTPN4 and PTPN3, are both dispensable for T cell receptor signal transduction. PLoS ONE. 2008, 3: e4014-10.1371/journal.pone.0004014.PubMedPubMedCentralCrossRef
18.
go back to reference Pilecka I, Patrignani C, Pescini R, Curchod ML, Perrin D, Xue Y: Protein-tyrosine phosphatase H1 controls growth hormone receptor signaling and systemic growth. J Biol Chem. 2007, 282: 35405-35415. 10.1074/jbc.M705814200.PubMedCrossRef Pilecka I, Patrignani C, Pescini R, Curchod ML, Perrin D, Xue Y: Protein-tyrosine phosphatase H1 controls growth hormone receptor signaling and systemic growth. J Biol Chem. 2007, 282: 35405-35415. 10.1074/jbc.M705814200.PubMedCrossRef
19.
go back to reference Hargreaves K, Dubner R, Brown F, Flores C, Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988, 32: 77-88. 10.1016/0304-3959(88)90026-7.PubMedCrossRef Hargreaves K, Dubner R, Brown F, Flores C, Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988, 32: 77-88. 10.1016/0304-3959(88)90026-7.PubMedCrossRef
20.
go back to reference Moller KA, Berge OG, Hamers FP: Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: Effects of morphine and rofecoxib. J Neurosci Methods. 2008, 174: 1-9. 10.1016/j.jneumeth.2008.06.017.CrossRef Moller KA, Berge OG, Hamers FP: Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: Effects of morphine and rofecoxib. J Neurosci Methods. 2008, 174: 1-9. 10.1016/j.jneumeth.2008.06.017.CrossRef
21.
go back to reference Gabriel AF, Marcus MA, Honig WM, Walenkamp GH, Joosten EA: The CatWalk method: a detailed analysis of behavioral changes after acute inflammatory pain in the rat. J Neurosci Methods. 2007, 163: 9-16. 10.1016/j.jneumeth.2007.02.003.PubMedCrossRef Gabriel AF, Marcus MA, Honig WM, Walenkamp GH, Joosten EA: The CatWalk method: a detailed analysis of behavioral changes after acute inflammatory pain in the rat. J Neurosci Methods. 2007, 163: 9-16. 10.1016/j.jneumeth.2007.02.003.PubMedCrossRef
22.
go back to reference Vrinten DH, Hamers FF: 'CatWalk' automated quantitative gait analysis as a novel method to assess mechanical allodynia in the rat; a comparison with von Frey testing. Pain. 2003, 102: 203-209. 10.1016/s0304-3959(02)00382-2.PubMedCrossRef Vrinten DH, Hamers FF: 'CatWalk' automated quantitative gait analysis as a novel method to assess mechanical allodynia in the rat; a comparison with von Frey testing. Pain. 2003, 102: 203-209. 10.1016/s0304-3959(02)00382-2.PubMedCrossRef
23.
go back to reference Sluka KA, Milton MA, Willis WD, Westlund KN: Differential roles of neurokinin 1 and neurokinin 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation. Br J Pharmacol. 1997, 120: 1263-1273. 10.1038/sj.bjp.0701044.PubMedPubMedCentralCrossRef Sluka KA, Milton MA, Willis WD, Westlund KN: Differential roles of neurokinin 1 and neurokinin 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation. Br J Pharmacol. 1997, 120: 1263-1273. 10.1038/sj.bjp.0701044.PubMedPubMedCentralCrossRef
24.
go back to reference Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.PubMedCrossRef Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.PubMedCrossRef
25.
go back to reference Bhattacharyya S, Dudeja PK, Tobacman JK: Carrageenan-induced NFkappaB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10. Biochim Biophys Acta. 2008, 1780: 973-982.PubMedPubMedCentralCrossRef Bhattacharyya S, Dudeja PK, Tobacman JK: Carrageenan-induced NFkappaB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10. Biochim Biophys Acta. 2008, 1780: 973-982.PubMedPubMedCentralCrossRef
26.
go back to reference Bhattacharyya S, Gill R, Chen ML, Zhang F, Linhardt RJ, Dudeja PK: Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J Biol Chem. 2008, 283: 10550-10558. 10.1074/jbc.M708833200.PubMedPubMedCentralCrossRef Bhattacharyya S, Gill R, Chen ML, Zhang F, Linhardt RJ, Dudeja PK: Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J Biol Chem. 2008, 283: 10550-10558. 10.1074/jbc.M708833200.PubMedPubMedCentralCrossRef
27.
go back to reference Posadas I, Bucci M, Roviezzo F, Rossi A, Parente L, Sautebin L: Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br J Pharmacol. 2004, 142: 331-338. 10.1038/sj.bjp.0705650.PubMedPubMedCentralCrossRef Posadas I, Bucci M, Roviezzo F, Rossi A, Parente L, Sautebin L: Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br J Pharmacol. 2004, 142: 331-338. 10.1038/sj.bjp.0705650.PubMedPubMedCentralCrossRef
28.
go back to reference Bucci M, Roviezzo F, Posadas I, Yu J, Parente L, Sessa WC: Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci USA. 2005, 102: 904-908. 10.1073/pnas.0408906102.PubMedPubMedCentralCrossRef Bucci M, Roviezzo F, Posadas I, Yu J, Parente L, Sessa WC: Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci USA. 2005, 102: 904-908. 10.1073/pnas.0408906102.PubMedPubMedCentralCrossRef
29.
go back to reference Rocha AC, Fernandes ES, Quintao NL, Campos MM, Calixto JB: Relevance of tumour necrosis factor-alpha for the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw. Br J Pharmacol. 2006, 148: 688-695. 10.1038/sj.bjp.0706775.PubMedPubMedCentralCrossRef Rocha AC, Fernandes ES, Quintao NL, Campos MM, Calixto JB: Relevance of tumour necrosis factor-alpha for the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw. Br J Pharmacol. 2006, 148: 688-695. 10.1038/sj.bjp.0706775.PubMedPubMedCentralCrossRef
30.
go back to reference Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997, 385: 729-733. 10.1038/385729a0.PubMedCrossRef Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997, 385: 729-733. 10.1038/385729a0.PubMedCrossRef
31.
go back to reference Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 1997, 385: 733-736. 10.1038/385733a0.PubMedCrossRef Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 1997, 385: 733-736. 10.1038/385733a0.PubMedCrossRef
32.
go back to reference Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC: An essential role for ectodomain shedding in mammalian development. Science. 1998, 282: 1281-1284. 10.1126/science.282.5392.1281.PubMedCrossRef Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC: An essential role for ectodomain shedding in mammalian development. Science. 1998, 282: 1281-1284. 10.1126/science.282.5392.1281.PubMedCrossRef
33.
go back to reference Rio C, Buxbaum JD, Peschon JJ, Corfas G: Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4. J Biol Chem. 2000, 275: 10379-10387. 10.1074/jbc.275.14.10379.PubMedCrossRef Rio C, Buxbaum JD, Peschon JJ, Corfas G: Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4. J Biol Chem. 2000, 275: 10379-10387. 10.1074/jbc.275.14.10379.PubMedCrossRef
34.
go back to reference Borrell-Pages M, Rojo F, Albanell J, Baselga J, Arribas J: TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J. 2003, 22: 1114-1124. 10.1093/emboj/cdg111.PubMedPubMedCentralCrossRef Borrell-Pages M, Rojo F, Albanell J, Baselga J, Arribas J: TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J. 2003, 22: 1114-1124. 10.1093/emboj/cdg111.PubMedPubMedCentralCrossRef
35.
go back to reference Sunnarborg SW, Hinkle CL, Stevenson M, Russell WE, Raska CS, Peschon JJ: Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem. 2002, 277: 12838-12845. 10.1074/jbc.M112050200.PubMedCrossRef Sunnarborg SW, Hinkle CL, Stevenson M, Russell WE, Raska CS, Peschon JJ: Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem. 2002, 277: 12838-12845. 10.1074/jbc.M112050200.PubMedCrossRef
36.
go back to reference Zheng Y, Schlondorff J, Blobel CP: Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1. J Biol Chem. 2002, 277: 42463-42470. 10.1074/jbc.M207459200.PubMedCrossRef Zheng Y, Schlondorff J, Blobel CP: Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1. J Biol Chem. 2002, 277: 42463-42470. 10.1074/jbc.M207459200.PubMedCrossRef
37.
go back to reference Loram LC, Fuller A, Fick LG, Cartmell T, Poole S, Mitchell D: Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw. J Pain. 2007, 8: 127-136. 10.1016/j.jpain.2006.06.010.PubMedCrossRef Loram LC, Fuller A, Fick LG, Cartmell T, Poole S, Mitchell D: Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw. J Pain. 2007, 8: 127-136. 10.1016/j.jpain.2006.06.010.PubMedCrossRef
38.
go back to reference Nantel F, Denis D, Gordon R, Northey A, Cirino M, Metters KM: Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Br J Pharmacol. 1999, 128: 853-859. 10.1038/sj.bjp.0702866.PubMedPubMedCentralCrossRef Nantel F, Denis D, Gordon R, Northey A, Cirino M, Metters KM: Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Br J Pharmacol. 1999, 128: 853-859. 10.1038/sj.bjp.0702866.PubMedPubMedCentralCrossRef
39.
go back to reference Beloeil H, Asehnoune K, Moine P, Benhamou D, Mazoit JX: Bupivacaine's action on the carrageenan-induced inflammatory response in mice: cytokine production by leukocytes after ex-vivo stimulation. Anesth Analg. 2005, 100: 1081-1086. 10.1213/01.ANE.0000146964.05212.65.PubMedCrossRef Beloeil H, Asehnoune K, Moine P, Benhamou D, Mazoit JX: Bupivacaine's action on the carrageenan-induced inflammatory response in mice: cytokine production by leukocytes after ex-vivo stimulation. Anesth Analg. 2005, 100: 1081-1086. 10.1213/01.ANE.0000146964.05212.65.PubMedCrossRef
40.
go back to reference Pilecka I, Patrignani C, Pescini R, Curchod ML, Perrin D, Xue Y: Protein-tyrosine Phosphatase H1 Controls Growth Hormone Receptor Signaling and Systemic Growth. J Biol Chem. 2007, 282: 35405-35415. 10.1074/jbc.M705814200.PubMedCrossRef Pilecka I, Patrignani C, Pescini R, Curchod ML, Perrin D, Xue Y: Protein-tyrosine Phosphatase H1 Controls Growth Hormone Receptor Signaling and Systemic Growth. J Biol Chem. 2007, 282: 35405-35415. 10.1074/jbc.M705814200.PubMedCrossRef
41.
go back to reference Salojin K, Oravecz T: Regulation of innate immunity by MAPK dual-specificity phosphatases: knockout models reveal new tricks of old genes. J Leukoc Biol. 2007, 81: 860-869. 10.1189/jlb.1006639.PubMedCrossRef Salojin K, Oravecz T: Regulation of innate immunity by MAPK dual-specificity phosphatases: knockout models reveal new tricks of old genes. J Leukoc Biol. 2007, 81: 860-869. 10.1189/jlb.1006639.PubMedCrossRef
42.
go back to reference Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T: Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol. 2006, 176: 1899-1907.PubMedCrossRef Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T: Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol. 2006, 176: 1899-1907.PubMedCrossRef
43.
go back to reference Roger T, Froidevaux C, Le RD, Reymond MK, Chanson AL, Mauri D: Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci USA. 2009, 106: 2348-2352. 10.1073/pnas.0808146106.PubMedPubMedCentralCrossRef Roger T, Froidevaux C, Le RD, Reymond MK, Chanson AL, Mauri D: Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci USA. 2009, 106: 2348-2352. 10.1073/pnas.0808146106.PubMedPubMedCentralCrossRef
44.
go back to reference Beutler B, Rietschel ET: Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol. 2003, 3: 169-176. 10.1038/nri1004.PubMedCrossRef Beutler B, Rietschel ET: Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol. 2003, 3: 169-176. 10.1038/nri1004.PubMedCrossRef
45.
go back to reference Roger T, Froidevaux C, Le RD, Reymond MK, Chanson AL, Mauri D: Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci USA. 2009 Roger T, Froidevaux C, Le RD, Reymond MK, Chanson AL, Mauri D: Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci USA. 2009
46.
go back to reference Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 2004, 4: 499-511. 10.1038/nri1391.PubMedCrossRef Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 2004, 4: 499-511. 10.1038/nri1391.PubMedCrossRef
48.
go back to reference Takeda K, Akira S: TLR signaling pathways. Semin Immunol. 2004, 16: 3-9. 10.1016/j.smim.2003.10.003.PubMedCrossRef Takeda K, Akira S: TLR signaling pathways. Semin Immunol. 2004, 16: 3-9. 10.1016/j.smim.2003.10.003.PubMedCrossRef
49.
go back to reference Takeuchi O, Akira S: [Roles of Toll-like receptor in host defense and the mechanism of its signal transduction]. Nippon Saikingaku Zasshi. 2004, 59: 523-529.PubMedCrossRef Takeuchi O, Akira S: [Roles of Toll-like receptor in host defense and the mechanism of its signal transduction]. Nippon Saikingaku Zasshi. 2004, 59: 523-529.PubMedCrossRef
50.
go back to reference Zughaier SM, Zimmer SM, Datta A, Carlson RW, Stephens DS: Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun. 2005, 73: 2940-2950. 10.1128/IAI.73.5.2940-2950.2005.PubMedPubMedCentralCrossRef Zughaier SM, Zimmer SM, Datta A, Carlson RW, Stephens DS: Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun. 2005, 73: 2940-2950. 10.1128/IAI.73.5.2940-2950.2005.PubMedPubMedCentralCrossRef
51.
go back to reference Grutz G: New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol. 2005, 77: 3-15.PubMed Grutz G: New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol. 2005, 77: 3-15.PubMed
52.
go back to reference Trinchieri G, Pflanz S, Kastelein RA: The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity. 2003, 19: 641-644. 10.1016/S1074-7613(03)00296-6.PubMedCrossRef Trinchieri G, Pflanz S, Kastelein RA: The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity. 2003, 19: 641-644. 10.1016/S1074-7613(03)00296-6.PubMedCrossRef
53.
go back to reference Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003, 3: 133-146. 10.1038/nri1001.PubMedCrossRef Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003, 3: 133-146. 10.1038/nri1001.PubMedCrossRef
54.
go back to reference Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991, 147: 3815-3822.PubMed Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991, 147: 3815-3822.PubMed
55.
go back to reference Wang P, Wu P, Siegel MI, Egan RW, Billah MM: IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol. 1994, 153: 811-816.PubMed Wang P, Wu P, Siegel MI, Egan RW, Billah MM: IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol. 1994, 153: 811-816.PubMed
56.
go back to reference Conti P, Kempuraj D, Kandere K, Di GM, Barbacane RC, Castellani ML: IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett. 2003, 86: 123-129. 10.1016/S0165-2478(03)00002-6.PubMedCrossRef Conti P, Kempuraj D, Kandere K, Di GM, Barbacane RC, Castellani ML: IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett. 2003, 86: 123-129. 10.1016/S0165-2478(03)00002-6.PubMedCrossRef
57.
go back to reference Vodovotz Y, Chow CC, Bartels J, Lagoa C, Prince JM, Levy RM: In silico models of acute inflammation in animals. Shock. 2006, 26: 235-244. 10.1097/01.shk.0000225413.13866.fo.PubMedCrossRef Vodovotz Y, Chow CC, Bartels J, Lagoa C, Prince JM, Levy RM: In silico models of acute inflammation in animals. Shock. 2006, 26: 235-244. 10.1097/01.shk.0000225413.13866.fo.PubMedCrossRef
58.
go back to reference Yoshimura A, Naka T, Kubo M: SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 2007, 7: 454-465. 10.1038/nri2093.PubMedCrossRef Yoshimura A, Naka T, Kubo M: SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 2007, 7: 454-465. 10.1038/nri2093.PubMedCrossRef
59.
go back to reference Tsuji-Takayama K, Suzuki M, Yamamoto M, Harashima A, Okochi A, Otani T: The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus. J Immunol. 2008, 181: 3897-3905.PubMedCrossRef Tsuji-Takayama K, Suzuki M, Yamamoto M, Harashima A, Okochi A, Otani T: The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus. J Immunol. 2008, 181: 3897-3905.PubMedCrossRef
60.
go back to reference Tsuji-Takayama K, Suzuki M, Yamamoto M, Harashima A, Okochi A, Otani T: IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT. Exp Hematol. 2008, 36: 181-192. 10.1016/j.exphem.2007.09.010.PubMedCrossRef Tsuji-Takayama K, Suzuki M, Yamamoto M, Harashima A, Okochi A, Otani T: IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT. Exp Hematol. 2008, 36: 181-192. 10.1016/j.exphem.2007.09.010.PubMedCrossRef
61.
go back to reference Pasquali C, Curchod ML, Walchli S, Espanel X, Guerrier M, Arigoni F: Identification of protein tyrosine phosphatases with specificity for the ligand-activated growth hormone receptor. Mol Endocrinol. 2003, 17: 2228-2239. 10.1210/me.2003-0011.PubMedCrossRef Pasquali C, Curchod ML, Walchli S, Espanel X, Guerrier M, Arigoni F: Identification of protein tyrosine phosphatases with specificity for the ligand-activated growth hormone receptor. Mol Endocrinol. 2003, 17: 2228-2239. 10.1210/me.2003-0011.PubMedCrossRef
62.
go back to reference DeForge LE, Remick DG: Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem Biophys Res Commun. 1991, 174: 18-24. 10.1016/0006-291X(91)90478-P.PubMedCrossRef DeForge LE, Remick DG: Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem Biophys Res Commun. 1991, 174: 18-24. 10.1016/0006-291X(91)90478-P.PubMedCrossRef
63.
go back to reference Kimura A, Naka T, Muta T, Takeuchi O, Akira S, Kawase I: Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT. Proc Natl Acad Sci USA. 2005, 102: 17089-17094. 10.1073/pnas.0508517102.PubMedPubMedCentralCrossRef Kimura A, Naka T, Muta T, Takeuchi O, Akira S, Kawase I: Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT. Proc Natl Acad Sci USA. 2005, 102: 17089-17094. 10.1073/pnas.0508517102.PubMedPubMedCentralCrossRef
64.
go back to reference Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M: Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol. 2000, 164: 3476-3479.PubMedCrossRef Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M: Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol. 2000, 164: 3476-3479.PubMedCrossRef
65.
go back to reference Schletter J, Heine H, Ulmer AJ, Rietschel ET: Molecular mechanisms of endotoxin activity. Arch Microbiol. 1995, 164: 383-389. 10.1007/BF02529735.PubMedCrossRef Schletter J, Heine H, Ulmer AJ, Rietschel ET: Molecular mechanisms of endotoxin activity. Arch Microbiol. 1995, 164: 383-389. 10.1007/BF02529735.PubMedCrossRef
66.
go back to reference Karin M: The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem. 1999, 274: 27339-27342. 10.1074/jbc.274.39.27339.PubMedCrossRef Karin M: The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem. 1999, 274: 27339-27342. 10.1074/jbc.274.39.27339.PubMedCrossRef
67.
go back to reference Goebeler M, Gillitzer R, Kilian K, Utzel K, Brocker EB, Rapp UR: Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. Blood. 2001, 97: 46-55. 10.1182/blood.V97.1.46.PubMedCrossRef Goebeler M, Gillitzer R, Kilian K, Utzel K, Brocker EB, Rapp UR: Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. Blood. 2001, 97: 46-55. 10.1182/blood.V97.1.46.PubMedCrossRef
68.
go back to reference Martin T, Cardarelli PM, Parry GC, Felts KA, Cobb RR: Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol. 1997, 27: 1091-1097. 10.1002/eji.1830270508.PubMedCrossRef Martin T, Cardarelli PM, Parry GC, Felts KA, Cobb RR: Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol. 1997, 27: 1091-1097. 10.1002/eji.1830270508.PubMedCrossRef
69.
go back to reference Park SK, Yang WS, Han NJ, Lee SK, Ahn H, Lee IK: Dexamethasone regulates AP-1 to repress TNF-alpha induced MCP-1 production in human glomerular endothelial cells. Nephrol Dial Transplant. 2004, 19: 312-319. 10.1093/ndt/gfg583.PubMedCrossRef Park SK, Yang WS, Han NJ, Lee SK, Ahn H, Lee IK: Dexamethasone regulates AP-1 to repress TNF-alpha induced MCP-1 production in human glomerular endothelial cells. Nephrol Dial Transplant. 2004, 19: 312-319. 10.1093/ndt/gfg583.PubMedCrossRef
70.
go back to reference Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, Sato S: Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol. 2001, 167: 5887-5894.PubMedCrossRef Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, Sato S: Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol. 2001, 167: 5887-5894.PubMedCrossRef
71.
go back to reference Zhang G, Ghosh S: Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest. 2001, 107: 13-19. 10.1172/JCI11837.PubMedPubMedCentralCrossRef Zhang G, Ghosh S: Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest. 2001, 107: 13-19. 10.1172/JCI11837.PubMedPubMedCentralCrossRef
72.
go back to reference Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ: Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem. 2000, 275: 11058-11063. 10.1074/jbc.275.15.11058.PubMedCrossRef Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ: Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem. 2000, 275: 11058-11063. 10.1074/jbc.275.15.11058.PubMedCrossRef
73.
go back to reference Carrithers M, Tandon S, Canosa S, Michaud M, Graesser D, Madri JA: Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am J Pathol. 2005, 166: 185-196.PubMedPubMedCentralCrossRef Carrithers M, Tandon S, Canosa S, Michaud M, Graesser D, Madri JA: Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am J Pathol. 2005, 166: 185-196.PubMedPubMedCentralCrossRef
74.
go back to reference Kamezaki K, Shimoda K, Numata A, Matsuda T, Nakayama K, Harada M: The role of Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals. Int Immunol. 2004, 16: 1173-1179. 10.1093/intimm/dxh118.PubMedCrossRef Kamezaki K, Shimoda K, Numata A, Matsuda T, Nakayama K, Harada M: The role of Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals. Int Immunol. 2004, 16: 1173-1179. 10.1093/intimm/dxh118.PubMedCrossRef
75.
go back to reference Matsuguchi T, Masuda A, Sugimoto K, Nagai Y, Yoshikai Y: JNK-interacting protein 3 associates with Toll-like receptor 4 and is involved in LPS-mediated JNK activation. EMBO J. 2003, 22: 4455-4464. 10.1093/emboj/cdg438.PubMedPubMedCentralCrossRef Matsuguchi T, Masuda A, Sugimoto K, Nagai Y, Yoshikai Y: JNK-interacting protein 3 associates with Toll-like receptor 4 and is involved in LPS-mediated JNK activation. EMBO J. 2003, 22: 4455-4464. 10.1093/emboj/cdg438.PubMedPubMedCentralCrossRef
76.
go back to reference Supinski GS, Ji X, Callahan LA: The JNK MAP kinase pathway contributes to the development of endotoxin-induced diaphragm caspase activation. Am J Physiol Regul Integr Comp Physiol. 2009, 297: R825-R834.PubMedPubMedCentralCrossRef Supinski GS, Ji X, Callahan LA: The JNK MAP kinase pathway contributes to the development of endotoxin-induced diaphragm caspase activation. Am J Physiol Regul Integr Comp Physiol. 2009, 297: R825-R834.PubMedPubMedCentralCrossRef
77.
go back to reference Edwards DR, Handsley MM, Pennington CJ: The ADAM metalloproteinases. Mol Aspects Med. 2008, 29: 258-289. 10.1016/j.mam.2008.08.001.PubMedCrossRef Edwards DR, Handsley MM, Pennington CJ: The ADAM metalloproteinases. Mol Aspects Med. 2008, 29: 258-289. 10.1016/j.mam.2008.08.001.PubMedCrossRef
78.
go back to reference Kirkegaard T, Naresh A, Sabine VS, Tovey SM, Edwards J, Dunne B: Expression of tumor necrosis factor alpha converting enzyme in endocrine cancers. Am J Clin Pathol. 2008, 129: 735-743. 10.1309/N6YB6YDVF58YCNHN.PubMedCrossRef Kirkegaard T, Naresh A, Sabine VS, Tovey SM, Edwards J, Dunne B: Expression of tumor necrosis factor alpha converting enzyme in endocrine cancers. Am J Clin Pathol. 2008, 129: 735-743. 10.1309/N6YB6YDVF58YCNHN.PubMedCrossRef
Metadata
Title
Characterization of protein tyrosine phosphatase H1 knockout mice in animal models of local and systemic inflammation
Authors
Claudia Patrignani
David T Lafont
Valeria Muzio
Béatrice Gréco
Rob Hooft van Huijsduijnen
Paola F Zaratin
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2010
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-7-16

Other articles of this Issue 1/2010

Journal of Inflammation 1/2010 Go to the issue